KPT-0127, a Novel, Potent and Selective Inhibitor of CRM1-Mediated Nuclear Export Shows Selective Cytotoxicity for the Treatment of Hematological Cancers
KPT-0127, a Novel, Potent and Selective Inhibitor of CRM1-Mediated Nuclear Export Shows Selective Cytotoxicity for the Treatment of Hematological Cancers